The Effectiveness of "Multi-Immunotherapy Special Training Courses Through Digital Media and Workshop" Intervention for Oncology Nurses: Exploration of Educational Needs, Curriculum Planning, Implementation and Evaluation
NCT05750199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124
Last updated 2023-08-16
Summary
This study is a 2-year qualitative and quantitative mixed method research project and consists of two phases.The study will provide useful clinical data to help us better understand educational needs of immunotherapy for oncology nurses. This ISTC model will lead to further validation of an oncology care training course model designed to better prepare and support cancer patients and their families to existing and new anti-cancer therapies.
Conditions
- Education
- Oncology
- Immune
Interventions
- OTHER
-
Immunotherapy Special Training Course (ISTC)
16 weeks and includes 8 hours of digital media training and 2 days of workshop training.
- OTHER
-
Advanced Oncology Nurse Training Course (AONTC)
4 weeks and includes 8 days of Advanced Oncology Nurse Training Course
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-28
- Primary Completion
- 2021-11-23
- Completion
- 2022-10-19
Countries
- Taiwan
Study Locations
More Related Trials
-
Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
NCT06954259 ·Status: ACTIVE_NOT_RECRUITING
-
Care Needs in Lung Cancer Patients Receiving Immunotherapy
NCT06433206 ·Status: RECRUITING
-
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
NCT06926179 ·Status: RECRUITING
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer
NCT01551251 ·Status: COMPLETED
-
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
NCT07035860 ·Status: NOT_YET_RECRUITING
-
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy
NCT04741633 ·Status: UNKNOWN
-
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
NCT02202655 ·Status: UNKNOWN
-
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI
NCT06100796 ·Status: RECRUITING
-
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
NCT02505139 ·Status: COMPLETED
-
Lung Cancer Patients and Parent-child Interaction Experience and Process
NCT06823505 ·Status: TERMINATED
-
Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC
NCT05725915 ·Status: UNKNOWN
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients
NCT01341210 ·Status: UNKNOWN
-
Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status
NCT05634551 ·Status: COMPLETED
-
Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer
NCT06262555 ·Status: RECRUITING ·Phase: NA
-
Radiogenomics in Aerodigestive Tract Cancers
NCT04314349 ·Status: COMPLETED
-
Immune-Marker Platform for Patients With Advanced Lung Cancer
NCT07150598 ·Status: NOT_YET_RECRUITING
-
Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer
NCT04160559 ·Status: WITHDRAWN ·Phase: NA
-
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes
NCT05792995 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT07166003 ·Status: RECRUITING
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator
NCT04352335 ·Status: COMPLETED
-
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
NCT06019455 ·Status: RECRUITING